AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 273: H634-H640, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erl, W.
Right arrow Articles by Weber, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erl, W.
Right arrow Articles by Weber, P. C.

AJP - Heart and Circulatory Physiology, Vol 273, Issue 2 634-H640, Copyright © 1997 by American Physiological Society

ARTICLES

alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization

W. Erl, C. Weber, C. Wardemann and P. C. Weber
Institut fur Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universitat, Munich, Germany.

The adherence of monocytes to activated endothelium is an early event in atherogenesis. Because antioxidants have been considered to be of antiatherosclerotic potential, we investigated the effects of alpha-tocopherol (TCP) and its acetate and succinate esters on monocyte adhesion to cytokine-stimulated human umbilical vein endothelial cells (HUVEC). Endothelial cells were treated with TCP, alpha-tocopherol acetate (TCP acetate), or alpha-tocopheryl succinate (TCP succinate) before stimulation with tumor necrosis factor-alpha (TNF-alpha; 10 U/ml, 6 h) or interleukin-1 beta (IL-1 beta; 10 U/ml, 6 h). Cytokine-stimulated cell surface expression of vascular cell adhesion molecule-1 (VCAM-1, CD106) and E-selectin (ELAM-1, CD62E), but not of intercellular adhesion molecule-1 (ICAM-1, CD54), was time- and dose-dependently inhibited by TCP succinate but not by TCP or TCP acetate. TCP succinate (200 microM, 24 h) reduced TNF-induced VCAM-1 and E-selectin expression from a specific mean fluorescence intensity of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively. Succinate alone had no effect. Decreased adhesion molecule expression was associated with a reduction of monocytic cell adhesion. TCP succinate (20 microM, 72 h), but not TCP (200 microM, 72 h), reduced U-937 cell adhesion to TNF-alpha-stimulated (10 U/ml, 6 h) HUVEC by 30% (P < 0.025) and to IL-1 beta-stimulated HUVEC by 56% (P < 0.010). Electrophoretic mobility-shift assays of HUVEC nuclear proteins revealed a decrease in TNF-alpha-stimulated nuclear factor-kappa B (NF-kappa B) activation after pretreatment of HUVEC with TCP succinate but not with TCP, TCP acetate, or succinate alone. In conclusion, we demonstrate that the vitamin E derivative TCP succinate prevents monocytic cell adhesion to cytokine-stimulated endothelial cells by inhibiting the activation of NF-kappa B, further emphasizing the antiatherosclerotic potential of lipid soluble antioxidants.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Pfrommer, W. Erl, and P. C. Weber
Docosahexaenoic acid induces ciap1 mRNA and protects human endothelial cells from stress-induced apoptosis
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2178 - H2186.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Weber, M. Lu, L. Andera, H. Lahm, N. Gellert, M. W. Fariss, V. Korinek, W. Sattler, D. S. Ucker, A. Terman, et al.
Vitamin E Succinate Is a Potent Novel Antineoplastic Agent with High Selectivity and Cooperativity with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (Apo2 Ligand) in Vivo
Clin. Cancer Res., March 1, 2002; 8(3): 863 - 869.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. L. Farre and S. Casado
Heart Failure, Redox Alterations, and Endothelial Dysfunction
Hypertension, December 1, 2001; 38(6): 1400 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. NEUZIL, T. WEBER, A. SCHRODER, M. LU, G. OSTERMANN, N. GELLERT, G. C. MAYNE, B. OLEJNICKA, A. NEGRE-SALVAYRE, M. STICHA, et al.
Induction of cancer cell apoptosis by {alpha}-tocopheryl succinate: molecular pathways and structural requirements
FASEB J, February 1, 2001; 15(2): 403 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
W. Erl, C. Weber, and G. K. Hansson
Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu2+ and Zn2+
Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1116 - C1125.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. Fruebis, M. Silvestre, D. Shelton, C. Napoli, and W. Palinski
Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits
J. Lipid Res., November 1, 1999; 40(11): 1958 - 1966.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Murase, N. Kume, T. Hase, Y. Shibuya, Y. Nishizawa, I. Tokimitsu, and T. Kita
Gallates Inhibit Cytokine-Induced Nuclear Translocation of NF-{kappa}B and Expression of Leukocyte Adhesion Molecules in Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1412 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. Erl, G. K. Hansson, R. de Martin, G. Draude, K. S. C. Weber, and C. Weber
Nuclear Factor-{kappa}B Regulates Induction of Apoptosis and Inhibitor of Apoptosis Protein-1 Expression in Vascular Smooth Muscle Cells
Circ. Res., April 2, 1999; 84(6): 668 - 677.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online